Valuation Brooks Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. 06:02:22 2026-08-21 EDT			5-day change	1st Jan Change
61.88 ^INR	+4.18%		-1.54%	-22.89%

08-13	Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-17	Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	1,514	1,801	1,540	2,457	3,167	1,093
Change	-	18.92%	-14.47%	59.5%	28.93%	-65.49%
Enterprise Value (EV) ¹	1,919	2,027	1,605	2,512	3,243	1,112
Change	-	5.63%	-20.83%	56.49%	29.1%	-65.72%
P/E	-7.82x	-11.1x	-7.37x	-12.2x	-28.6x	4.45x
PBR	1.91x	2.86x	2.08x	3.75x	3.19x	0.89x
PEG	-	0.7x	-0.3x	1.27x	0.6x	-0x
Capitalization / Revenue	1.95x	1.98x	2.44x	3.09x	3.84x	1.27x
EV / Revenue	2.47x	2.23x	2.54x	3.16x	3.93x	1.3x
EV / EBITDA	219x	-13.9x	-6x	70.2x	65.6x	15.3x
EV / EBIT	-32x	-9.38x	-4.81x	120x	88.1x	18.4x
EV / FCF	-20.4x	-4.22x	18.2x	-23.9x	-203x	37.1x
FCF Yield	-4.9%	-23.7%	5.49%	-4.18%	-0.49%	2.69%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-7.843	-6.553	-8.461	-7.648	-3.72	8.346
Distribution rate	-	-	-	-	-	-
Net sales ¹	778.1	910.8	632	794.9	825.6	857.4
EBITDA ¹	8.783	-145.4	-267.4	35.77	49.45	72.65
EBIT ¹	-60.03	-216	-334	20.94	36.8	60.26
Net income ¹	-193.8	-161.9	-209	-195.9	-99.67	245.8
Net Debt ¹	405	226.5	64.89	55.16	75.39	18.44
Reference price ²	61.30	72.90	62.35	93.60	106.36	37.11
Nbr of stocks (in thousands)	24,703	24,703	24,703	26,247	29,780	29,457
Announcement Date	9/7/21	9/6/22	8/30/23	8/28/24	9/4/25	8/12/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.1x	6.58x	22.81x	0.9%	47.71B
OTSUKA HOLDINGS CO., LTD.	18.6x	2.22x	10.04x	1.39%	40.3B
CIPLA LIMITED	27.88x	3.39x	17.57x	0.91%	12.09B
ZYDUS LIFESCIENCES LIMITED	26.85x	3.84x	15.92x	0.6%	11.68B
KRKA, D. D.	18.73x	3.33x	11.58x	3.85%	9.19B
GEDEON RICHTER	9.03x	2.08x	5.42x	4.46%	7.57B
ONO PHARMACEUTICAL CO., LTD.	15.95x	2.08x	6.76x	3.2%	7.24B
GLENMARK PHARMACEUTICALS LIMITED	28.19x	3.68x	17.11x	0.16%	6.84B
Average	22.54x	3.40x	13.40x	1.93%	17.83B
Weighted average by Cap.	25.41x	4.04x	15.46x	1.48%